Firms

Coronet Ventures

Singapore · Rotterdam, Netherlands

Coronet Ventures is Cedars-Sinai Intellectual Property Company’s international healthcare and biomedical investment initiative. The Singapore platform was announced in May 2023 as Coronet Ventures (Singapore) Pte. Ltd., a co-investment partner of SEEDS Capital under Startup SG Equity. The current brand also covers Coronet Ventures Netherlands, launched in June 2025; its Dutch alternative-fund manager is CV PB Management Company B.V. These regional legal entities are qualified within the shared platform rather than conflated with Cedars-Sinai Medical Center or another pharmaceutical investor. Coronet targets early-stage healthcare and biomedical companies with potential for the U.S. market, connecting portfolio companies to Cedars-Sinai clinical validation, research, commercialization and accelerator resources. Its current published investment strategy is Seed and Series A, with indicative checks of US$500,000–3 million. Its portfolio includes AI drug discovery and respiratory monitoring, medical devices and digital health. CEO Nirdesh Gupta leads the initiative; the published regional teams, advisers and board affiliations are explicitly scoped. The Netherlands strategy’s announced US$50 million deployment over ten years is not a verified closed LP fundraise, and the parent’s equity assets are not Coronet fund capital.

Founded: 2023
Type: Venture capital

Funds2

Coronet Ventures Netherlands2025-06-182025-06-18—
Named Dutch venture fund launched by Cedars-Sinai Technology Ventures in June2025, with public parent announcement June18. Own disclaimer names CV PB Management Company B.V. as alternative-fund manager. USD50M to be invested over the next decade is a deployment plan, not confirmed closed LP capital; structured raised amount remains NULL.
Coronet Ventures Singapore2023-05-252023-05-25—
Singapore investment platform announced as Coronet Ventures (Singapore) Pte. Ltd. and CSIP’s first foreign investment entity. Current primary parent identifies this named international investment fund. Government co-investment partnership and check/deployment targets are verified; no independently disclosed closed fund amount is verified.

Team

Operations and support

Alex ChaiVice President and General Counsel

Colin TanInvestment Director and Data Protection Officer — Singapore

David WrigleyBoard member (Cedars-Sinai Health System EVP and CFO)

Edward PrunchunasBoard member (Cedars-Sinai Intellectual Property Company board)

James LaurBoard member (President, Cedars-Sinai Intellectual Property Company)

Koen van BreugelInvestment Director — Netherlands

Michael DooijesStrategic Advisor — Netherlands

Nirdesh GuptaChief Executive Officer; Managing Partner — Netherlands

Peter PostStrategic Advisor — Netherlands

Co-investing

ClavystBio

Engine Biosciences$27M · 2023-10-31

EDBI

Engine Biosciences$27M · 2023-10-31

Polaris Partners

Engine Biosciences$27M · 2023-10-31

SEEDS Capital

Engine Biosciences$27M · 2023-10-31

The Invus Group, LLC

Engine Biosciences$27M · 2023-10-31

Investments

$7M2024-08-12	Aevice Health	Coronet Ventures
$27M2023-10-31	Engine Biosciences	Polaris Partners, ClavystBio, SEEDS Capital, EDBI, Coronet Ventures, The Invus Group, LLC

team@apexlogos.ai18 hours ago
Reviewed 7 October 2026. Coronet belongs to Cedars-Sinai Intellectual Property Company, not Novo Holdings, Novo Nordisk or their foundation. Shared brand covers separately qualified Singapore and Dutch legal/platform identities. All nine published people have authentic own card portraits available; Nirdesh Gupta’s existing portrait, biography facts, Aevice role and Engine observer role are preserved. Three board members are not imported as inferred employees; two Netherlands advisers are qualified. Two named international fund/platform launches have NULL closed-capital amounts. Dutch USD50M decade deployment target and parent USD1B equity AUM are not funds raised. Singapore page publishes six portfolio companies; Netherlands four. Partners and accelerator collaboration are distinct from manager cash investments. Engine batch521 owns the sole specific October2023 extension participation; no 2018/2021 Coronet checks inferred.